Viro Missile
La Jolla
About Viro Missile
ViroMissile is a biotechnology company that develops oncolytic virus therapies that target and destroy tumor cells. Their primary product is the IDOV-Stealth virus, designed to evade the immune system while treating various cancers. The company aims to create a cure for cancer with results in animal models showing prolonged survival.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Funding stage: Seed
- Last round: Seed (Mar 2021)
- Website: viromissile.com
Industries & Categories
Biotechnology, Health Care, Life Science, Oncology, Pharmaceutical
Canonical: https://fsome.com/organization/viro-missile-21968 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.